Natures Sunshine Products (NATR) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $12.64, +0.00% vs the prior close of $12.64.
- Volume 95.15K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NATR ends flat (+0.0%) to $12.64. Closed at $12.64, +0.00% vs the prior close of $12.64. Day range $12.61–$12.93, opened at $12.67.
NATR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NATR ends flat (+0.0%) to $12.64
- Closed at $12.64, +0.00% vs the prior close of $12.64. Day range $12.61–$12.93, opened at $12.67.
- Volume was 95.15K shares, 0.5x its 50-day average of 177.29K — lighter than usual.
- Price is -7.4% vs its 50-day average ($13.65) and -39.9% vs its 200-day average ($21.02).
- 52-week range $12.00–$28.14; today's close sits at 4% of that range, 55.1% below the 52-week high.
Oct 15, 2026 — NATR ends flat (+0.2%) to $12.64
- Closed at $12.64, +0.24% vs the prior close of $12.61. Day range $12.00–$13.04, opened at $12.00.
- Volume was 87.40K shares, 0.5x its 50-day average of 177.60K — lighter than usual.
- Price is -8.4% vs its 50-day average ($13.80) and -40.0% vs its 200-day average ($21.07).
- 52-week range $12.00–$28.14; today's close sits at 4% of that range, 55.1% below the 52-week high.
Oct 14, 2026 — NATR dips 1.2% to $12.61
- Closed at $12.61, -1.18% vs the prior close of $12.76. Day range $12.50–$12.86, opened at $12.75.
- Volume was 117.80K shares, 0.7x its 50-day average of 177.34K.
- Price is -9.6% vs its 50-day average ($13.95) and -40.3% vs its 200-day average ($21.12).
- 52-week range $12.31–$28.14; today's close sits at 2% of that range, 55.2% below the 52-week high.
Oct 13, 2026 — NATR rises 0.4% to $12.76, 3 up days in a row
- Closed at $12.76, +0.39% vs the prior close of $12.71. Day range $12.73–$12.88, opened at $12.76.
- Volume was 103.90K shares, 0.6x its 50-day average of 178.47K — lighter than usual.
- Price is -9.5% vs its 50-day average ($14.11) and -39.7% vs its 200-day average ($21.16).
- 52-week range $12.31–$28.14; today's close sits at 3% of that range, 54.7% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — NATR rises 0.6% to $12.71
- Closed at $12.71, +0.55% vs the prior close of $12.64. Day range $12.50–$12.81, opened at $12.65.
- Volume was 99.50K shares, 0.6x its 50-day average of 178.44K — lighter than usual.
- Price is -11.0% vs its 50-day average ($14.27) and -40.1% vs its 200-day average ($21.21).
- 52-week range $12.31–$28.14; today's close sits at 3% of that range, 54.8% below the 52-week high.
Oct 9, 2026 — NATR rises 0.6% to $12.64
- Closed at $12.64, +0.56% vs the prior close of $12.57. Day range $12.49–$12.73, opened at $12.57.
- Volume was 75.90K shares, 0.4x its 50-day average of 179.08K — lighter than usual.
- Price is -12.4% vs its 50-day average ($14.42) and -40.5% vs its 200-day average ($21.25).
- 52-week range $12.31–$28.14; today's close sits at 2% of that range, 55.1% below the 52-week high.
Oct 8, 2026 — NATR ends flat (-0.2%) to $12.57
- Closed at $12.57, -0.16% vs the prior close of $12.59. Day range $12.38–$12.58, opened at $12.54.
- Volume was 115.10K shares, 0.6x its 50-day average of 179.01K.
- Price is -13.8% vs its 50-day average ($14.58) and -41.0% vs its 200-day average ($21.30).
- 52-week range $12.31–$28.14; today's close sits at 2% of that range, 55.3% below the 52-week high.
Oct 7, 2026 — NATR rises 0.4% to $12.59
- Closed at $12.59, +0.40% vs the prior close of $12.54. Day range $12.44–$12.75, opened at $12.44.
- Volume was 107.90K shares, 0.6x its 50-day average of 178.61K.
- Price is -14.6% vs its 50-day average ($14.74) and -41.0% vs its 200-day average ($21.35).
- 52-week range $12.31–$28.14; today's close sits at 2% of that range, 55.3% below the 52-week high.
Oct 6, 2026 — NATR rises 1.1% to $12.54
- Closed at $12.54, +1.13% vs the prior close of $12.40. Day range $12.35–$12.67, opened at $12.45.
- Volume was 104.40K shares, 0.6x its 50-day average of 178.72K — lighter than usual.
- Price is -15.8% vs its 50-day average ($14.90) and -41.4% vs its 200-day average ($21.40).
- 52-week range $12.31–$28.14; today's close sits at 1% of that range, 55.4% below the 52-week high.
Oct 5, 2026 — NATR dips 0.4% to $12.40, a 52-week low, 6 down days in a row
- Closed at $12.40, -0.40% vs the prior close of $12.45. Day range $12.31–$12.57, opened at $12.56.
- Volume was 126.90K shares, 0.7x its 50-day average of 177.99K.
- Price is -17.7% vs its 50-day average ($15.06) and -42.2% vs its 200-day average ($21.45).
- 52-week range $12.31–$28.14; today's close sits at 1% of that range, 55.9% below the 52-week high.
- That makes 6 straight losses.
Oct 2, 2026 — NATR dips 1.1% to $12.45, a 52-week low, 5 down days in a row
- Closed at $12.45, -1.11% vs the prior close of $12.59. Day range $12.32–$12.89, opened at $12.70.
- Volume was 145.50K shares, 0.8x its 50-day average of 177.57K.
- Price is -18.2% vs its 50-day average ($15.22) and -42.1% vs its 200-day average ($21.50).
- 52-week range $12.32–$28.14; today's close sits at 1% of that range, 55.8% below the 52-week high.
- That makes 5 straight losses.
NATR latest news & SEC filings
Every SEC filing by or about NATR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 14, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 19, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Frohlich Phil bought 20,000 shares at $14.69 (≈$293.80K) on Aug 17, 2026
- Frohlich Phil bought 20,000 shares at $14.69 (≈$293.80K) on Aug 17, 2026
- Prescott Group Aggressive Small Cap Ii Lp bought 20,000 shares at $14.69 (≈$293.80K) on Aug 17, 2026
- Prescott Group Aggressive Small Cap Ii Lp bought 20,000 shares at $14.69 (≈$293.80K) on Aug 17, 2026
- Prescott Group Capital Management, L.L.C. bought 20,000 shares at $14.69 (≈$293.80K) on Aug 17, 2026
- Prescott Group Capital Management, L.L.C. bought 20,000 shares at $14.69 (≈$293.80K) on Aug 17, 2026
- …plus 14 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Prescott Group Capital Management, L.L.C. bought 10,000 shares at $16.01 (≈$160.10K) on Aug 10, 2026
- Prescott Group Capital Management, L.L.C. bought 13,072 shares at $15.78 (≈$206.28K) on Aug 10, 2026
- Prescott Group Capital Management, L.L.C. bought 16,928 shares at $15.80 (≈$267.46K) on Aug 10, 2026
- Prescott Group Capital Management, L.L.C. bought 876 shares at $15.64 (≈$13.70K) on Aug 10, 2026
- Prescott Group Capital Management, L.L.C. bought 10,000 shares at $16.01 (≈$160.10K) on Aug 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 10, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $116.98M (prior year $114.75M) (+1.9% vs Jun 30, 2025)
- Net income: $3.54M (prior year $5.33M) (-33.7% vs Jun 30, 2025)
- Diluted EPS: $0.19 (prior year $0.28) (-32.1% vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade NATR
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 10, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.63% (largest 2.0%). That is a relatively calm stock.
- Liquidity: about 104.31K shares (≈$1.32M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $12.64 vs a range of $12.00–$28.14 (4% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Phil Frohlich bought 20,000 shares on Aug 17, 2026.
- Latest filings: 10-Q Aug 6, 2026; 8-K Aug 6, 2026; 8-K May 11, 2026.
- Share count: 17.60M shares outstanding (Jul 24, 2026), -0.2% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
NATR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 12.67 | 12.93 | 12.61 | 12.64 | 95.15K |
| Oct 15, 2026 | 12.00 | 13.04 | 12.00 | 12.64 | 87.40K |
| Oct 14, 2026 | 12.75 | 12.86 | 12.50 | 12.61 | 117.80K |
| Oct 13, 2026 | 12.76 | 12.88 | 12.73 | 12.76 | 103.90K |
| Oct 12, 2026 | 12.65 | 12.81 | 12.50 | 12.71 | 99.50K |
| Oct 9, 2026 | 12.57 | 12.73 | 12.49 | 12.64 | 75.90K |
| Oct 8, 2026 | 12.54 | 12.58 | 12.38 | 12.57 | 115.10K |
| Oct 7, 2026 | 12.44 | 12.75 | 12.44 | 12.59 | 107.90K |
| Oct 6, 2026 | 12.45 | 12.67 | 12.35 | 12.54 | 104.40K |
| Oct 5, 2026 | 12.56 | 12.57 | 12.31 | 12.40 | 126.90K |
| Oct 2, 2026 | 12.70 | 12.89 | 12.32 | 12.45 | 145.50K |
| Oct 1, 2026 | 12.69 | 12.75 | 12.51 | 12.59 | 160.00K |
| Sep 30, 2026 | 12.66 | 12.83 | 12.53 | 12.69 | 132.50K |
| Sep 29, 2026 | 12.82 | 12.89 | 12.73 | 12.76 | 64.40K |
| Sep 28, 2026 | 12.92 | 13.08 | 12.68 | 12.83 | 100.60K |
| Sep 25, 2026 | 12.88 | 12.94 | 12.81 | 12.92 | 77.30K |
| Sep 24, 2026 | 12.94 | 12.96 | 12.72 | 12.91 | 130.10K |
| Sep 23, 2026 | 13.22 | 13.28 | 12.94 | 12.95 | 56.70K |
| Sep 22, 2026 | 13.09 | 13.47 | 13.07 | 13.22 | 98.40K |
| Sep 21, 2026 | 13.01 | 13.22 | 12.99 | 13.02 | 86.70K |
About Natures Sunshine Products
Natures Sunshine Products (NATR) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in LEHI, UT. State of incorporation: UT. Fiscal year ends December 31. SEC CIK 275053.
NATR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Steven J. Fasching | Director | May 20, 2026 |
| Curtis Kopf | Director | May 19, 2026 |
| Katie May | Director | May 19, 2026 |
| Tess Roering | Director | May 19, 2026 |
| Kenneth G. Romanzi | Chief Executive Officer | May 19, 2026 |
| Robert D Straus | Director | May 19, 2026 |
| Heidi Wissmiller | Director | May 19, 2026 |
| Rong Yang | Director | May 19, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Nathan G Brower | EVP, General Counsel | May 22, 2026 |
| Erich A Fritz | EVP, Global Supply Chain | May 19, 2026 |
| Kevin Gregory Fuller | Global Chief Marketing Officer | May 19, 2026 |
| Martin A. Gonzalez | EVP, Global Supply Chain | Nov 6, 2025 |
| Kevin R. Herbert | EVP & President, North America | Jun 29, 2026 |
| Leslie Shane Jones | EVP & Chief Financial Officer | May 7, 2026 |
| Jonathan David Lanoy | SVP, Chief Accounting Officer | Sep 3, 2026 |
| Daniel C Norman | EVP & President, Asia | Jun 3, 2026 |
| Ruth Ann Perkins | EVP, Chief Financial Officer | Sep 15, 2026 |
| Kenneth G. Romanzi | Chief Executive Officer | May 19, 2026 |
| Bryant J Yates | EVP & President, Europe | Jun 11, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 17, 2026 | Phil Frohlich | Buy | 20,000 | $14.69 |
| Aug 17, 2026 | Phil Frohlich | Buy | 20,000 | $14.69 |
| Aug 17, 2026 | Group Aggressive Small Cap Ii Lp Prescott | Buy | 20,000 | $14.69 |
| Aug 17, 2026 | Group Aggressive Small Cap Ii Lp Prescott | Buy | 20,000 | $14.69 |
| Aug 17, 2026 | Group Capital Management, L.L.C. Prescott | Buy | 20,000 | $14.69 |
| Aug 17, 2026 | Group Capital Management, L.L.C. Prescott | Buy | 20,000 | $14.69 |
| Aug 17, 2026 | Group Aggressive Small Cap Lp Prescott | Buy | 20,000 | $14.69 |
| Aug 17, 2026 | Group Aggressive Small Cap Lp Prescott | Buy | 20,000 | $14.69 |
| Aug 17, 2026 | Group Aggressive Small Cap Master Fund Gp Prescott | Buy | 20,000 | $14.69 |
| Aug 17, 2026 | Group Aggressive Small Cap Master Fund Gp Prescott | Buy | 20,000 | $14.69 |
| Aug 17, 2026 | Phil Frohlich | Buy | 20,000 | $14.69 |
| Aug 17, 2026 | Phil Frohlich | Buy | 20,000 | $14.69 |
| Aug 17, 2026 | Group Aggressive Small Cap Ii Lp Prescott | Buy | 20,000 | $14.69 |
| Aug 17, 2026 | Group Aggressive Small Cap Ii Lp Prescott | Buy | 20,000 | $14.69 |
| Aug 17, 2026 | Group Capital Management, L.L.C. Prescott | Buy | 20,000 | $14.69 |
NATR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $480.14M | $19.52M | 1.06 | $35.32M |
| Dec 31, 2024 | $454.36M | $7.70M | 0.40 | $25.30M |
| Dec 31, 2023 | $445.32M | $15.08M | 0.77 | $41.23M |
| Dec 31, 2022 | $421.91M | $-390.00K | -0.02 | $710.00K |
| Dec 31, 2021 | $444.08M | — | 1.42 | $34.61M |
Latest balance sheet: total assets $259.82M, total liabilities $90.51M, cash $82.50M (as of Jun 30, 2026).
NATR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $20.34 |
| May 7, 2026 | 8-K Item 2.02 (results) | $24.55 |
| Mar 10, 2026 | 8-K Item 2.02 (results) | $25.08 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $13.73 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $14.01 |
| Mar 12, 2025 | 8-K Item 2.02 (results) | $13.52 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $13.86 |
| Aug 9, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Mar 12, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
| Aug 10, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NATR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.